Virtus ETF Advisers LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,618
-59.5%
18,216
-9.0%
0.02%
-58.9%
Q2 2023$95,319
+153.9%
20,025
+204.1%
0.06%
+166.7%
Q1 2023$37,535
-59.2%
6,585
-27.7%
0.02%
-56.2%
Q4 2022$91,950
-27.0%
9,113
+62.5%
0.05%
-4.0%
Q3 2022$126,000
-8.7%
5,607
+0.7%
0.05%
-2.0%
Q2 2022$138,000
+15.0%
5,566
+80.1%
0.05%
-5.6%
Q1 2022$120,000
-37.5%
3,091
-5.6%
0.05%
-26.0%
Q4 2021$192,000
+37.1%
3,274
+39.0%
0.07%
+17.7%
Q3 2021$140,000
-35.2%
2,356
-5.2%
0.06%
-30.3%
Q2 2021$216,000
-15.6%
2,486
-20.1%
0.09%
-17.6%
Q1 2021$256,000
-7.9%
3,110
+1.6%
0.11%
-6.1%
Q4 2020$278,000
-30.7%
3,061
-69.5%
0.12%
-45.2%
Q3 2020$401,000
+2.6%
10,028
-12.0%
0.21%
+13.5%
Q2 2020$391,000
-8.0%
11,389
-40.5%
0.18%
+5.7%
Q1 2020$425,000
-0.9%
19,135
-12.7%
0.18%
+150.0%
Q4 2019$429,000
+95.0%
21,917
+54.6%
0.07%
+59.1%
Q3 2019$220,000
-27.6%
14,176
-5.3%
0.04%
-31.2%
Q2 2019$304,000
+4.1%
14,965
-9.9%
0.06%
-89.7%
Q1 2019$292,000
+24.3%
16,612
-9.4%
0.62%
+1452.5%
Q4 2018$235,000
-62.2%
18,340
-51.9%
0.04%
-37.5%
Q3 2018$621,000
-17.1%
38,094
-42.3%
0.06%
-90.3%
Q2 2018$749,00066,0730.66%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders